P483 Faecal calprotectin exhibits diurnal variation in inflammatory bowel disease patients but is not affected by time of day
نویسندگان
چکیده
منابع مشابه
Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
Crohn's disease and ulcerative colitis are chronic relapsing gastrointestinal conditions characterised by an influx of inflammatory cells to the affected gut mucosa. The mainstay of diagnosing and re-evaluating these conditions in clinical practice and research is by invasive serological, radiological, endoscopic and histological assessment. In clinical trials, disease activity is often evaluat...
متن کاملPrognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease
Postprint This is the accepted version of a paper published in Alimentary Pharmacology and Therapeutics. This paper has been peer-reviewed but does not include the final publisher proof-corrections or journal pagination. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease. Access to the published version may require subscription. Abstract Back...
متن کاملFaecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
OBJECTIVE To evaluate whether including a test for faecal calprotectin, a sensitive marker of intestinal inflammation, in the investigation of suspected inflammatory bowel disease reduces the number of unnecessary endoscopic procedures. DESIGN Meta-analysis of diagnostic accuracy studies. DATA SOURCES Studies published in Medline and Embase up to October 2009. Interventions reviewed Measure...
متن کاملFaecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
The present study aimed to investigate faecal calprotectin as a diagnostic marker to differentiate between patients with inflammatory bowel disease (IBD) and those with irritable bowel syndrome (IBS). A total of 20 healthy control subjects, 26 patients with IBS and 58 patients with IBD, including 22 with ulcerative colitis (UC) and 36 with Crohn's disease (CD), were recruited for the present st...
متن کاملFaecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
OBJECTIVE In primary care, assessing which patients with bowel symptoms harbour significant disease (cancer, higher-risk adenoma or IBD) is difficult. We studied the diagnostic accuracies of faecal haemoglobin (FHb) and faecal calprotectin (FC) in a cohort of symptomatic patients. DESIGN From October 2013 to March 2014, general practitioners were prompted to request FHb and FC when referring ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Crohn's and Colitis
سال: 2014
ISSN: 1873-9946
DOI: 10.1016/s1873-9946(14)60603-6